European Journal of Surgical Oncology
Volume 34, Issue 6 , Pages 631-635 , June 2008

The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast

  • R.F.D. van la Parra

      Affiliations

    • Department of Surgery, Jeroen Bosch Ziekenhuis, P.O. Box 90153, 5200 ME ’s-Hertogenbosch, The Netherlands
    • ,
  • M.F. Ernst

      Affiliations

    • Department of Surgery, Jeroen Bosch Ziekenhuis, P.O. Box 90153, 5200 ME ’s-Hertogenbosch, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 73 699 2701; fax: +31 73 699 2163.
    • ,
  • P.C. Barneveld

      Affiliations

    • Department of Nuclear Medicine, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch, The Netherlands
    • ,
  • J.M. Broekman

      Affiliations

    • Department of Pathology, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch, The Netherlands
    • ,
  • M.J.C.M. Rutten

      Affiliations

    • Department of Radiology, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch, The Netherlands
    • ,
  • K. Bosscha

      Affiliations

    • Department of Surgery, Jeroen Bosch Ziekenhuis, P.O. Box 90153, 5200 ME ’s-Hertogenbosch, The Netherlands

,Accepted 6 August 2007.

References 

  1. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?. Am Surg. 2001;67(6):513–519
  2. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. Ann Surg Oncol. 2000;7(9):636–642
  3. Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer. 2003;98(10):2105–2113
  4. Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg. 2003;138(3):309–313
  5. Krag D, Weaver D, Ashikaga T, Moffat F, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339(14):941–946
  6. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186(3):275–283
  7. Ohtake E, Asaga T, Inaba M. Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsy. Ann Nucl Med. 2005;19(8):671–675
  8. Trifiro G, Lavinia TL, De Cicco C, Paganelli G. Sentinel node detection and radioguided occult lesion localization in breast cancer. Phys Med. 2006;21(Suppl. 1):20–23
  9. Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9(3):272–277
  10. Zavotsky J, Hansen N, Brennan MB, Turner RR, Giuliano AE. Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer. 1999;85(11):2439–2443
  11. Cserni G. Sentinel lymph node biopsy as a tool for the staging of ductal carcinoma in situ in patients with breast carcinoma. Surg Today. 2002;32(2):99–103
  12. Intra M, Soteldo J, Bassani G. Sentinel lymph node biopsy in ductal carcinoma in situ of the male breast. Breast J. 2005;11(2):154
  13. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal breast carcinoma—is it indicated?. Cancer. 1987;59(10):1819–1824
  14. Veronesi P, Intra M, Vento AR, et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ?. Breast. 2005;14(6):520–522
  15. Kelly TA, Kim JA, Patrick R, Grundfest S, Crowe JP. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg. 2003;186(4):368–370
  16. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol. 2000;7(1):15–20
  17. Boecker W, Parker S, Schulz-Wendtland R, Schnitt A, Buerger H. Ductal carcinoma in situ. In:  Boecker W editors. Preneoplasia of the breast: a new conceptual approach to proliferative breast disease. 1st ed.. Saunders; 2006;p. 408–462
  18. CBO . Richtlijn behandeling van het mammacarcinoom. Van Zuiden Communications BV; 2005;
  19. Intra M, Zurrida S, Maffini F, et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol. 2003;10(10):1160–1165
  20. Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg. 2005;62(2):253–257
  21. Farkas EA, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. An argument against routine sentinel node mapping for DCIS. Am Surg. 2004;70(1):13–17
  22. Rahusen FD, Meijer S, Taets van Amerongen AH, Pijpers R, van Diest PJ. Sentinel node biopsy for nonpalpable breast tumors requires a preoperative diagnosis of invasive breast cancer. Breast J. 2003;9(5):380–384
  23. Camp R, Feezor R, Kasraeian A, et al. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida. Breast J. 2005;11(6):394–397
  24. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg. 2003;138(5):482–487
  25. Moran CJ, Kell MR, Kerin MJ. The role of sentinel lymph node biopsy in ductal carcinoma in situ. Eur J Surg Oncol. 2005;31(10):1105–1111
  26. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997;80(7):1188–1197

PII: S0748-7983(07)00490-8

doi: 10.1016/j.ejso.2007.08.003

European Journal of Surgical Oncology
Volume 34, Issue 6 , Pages 631-635 , June 2008

Article Tools